GSK
GSK plc
36.56
USD
This page is just a preview of the data found in TrendSpider’s full version
GSK plc stock is up 6.99% since 30 days ago. The next earnings date is Jan 31, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 62% of the previous 50 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 4 PUTs, 6 CALLs.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 15 Nov 15:14 | 17 Jan, 2025 | 47.00 | 62 | ||
| 15 Nov 15:30 | 17 May, 2024 | 25.00 | 100 | ||
| 15 Nov 16:08 | 17 Jan, 2025 | 50.00 | 46 | ||
| 15 Nov 20:08 | 17 Nov, 2023 | 33.00 | 412 | ||
| 16 Nov 19:18 | 17 Jan, 2025 | 25.00 | 28 | ||
| 17 Nov 16:13 | 17 May, 2024 | 36.00 | 239 | ||
| 20 Nov 14:37 | 19 Jan, 2024 | 36.00 | 1561 | ||
| 20 Nov 20:06 | 19 Jan, 2024 | 45.00 | 30 | ||
| 30 Nov 14:47 | 17 May, 2024 | 34.00 | 38 | ||
| 01 Dec 19:39 | 17 Jan, 2025 | 37.00 | 703 |
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital.
